On April 23, 2026, Pfizer Inc. held its Annual Shareholders Meeting where key proposals were approved, including the election of board members and an independent auditor, while a proposal for an independent chair was rejected. Notably, 3,442,653,662 votes were cast in favor of Ronald E. Blaylock's election, while 1,015,206,372 votes favored the independent chair policy which did not pass.